Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1-Reference-Cited by-同舟云学术

Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1

Published:2002-09 Issue:5 Volume:74 Page:591-598
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Tullius Stefan G.,Nieminen-Kelh?? Melina,Buelow Roland,Reutzel-Selke Anja,Martins Paulo N.,Pratschke Johann,Bachmann Ulrike,Lehmann Manfred,Southard Daniel,Iyer Suhasani,Schmidbauer Georg,Sawitzki Birgit,Reinke Petra,Neuhaus Peter,Volk Hans-Dieter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference34 articles.

1. Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996

2. BOTH ALLOANTIGEN-DEPENDENT AND -INDEPENDENT FACTORS INFLUENCE CHRONIC ALLOGRAFT REJECTION

3. Contribution of Prolonged Ischemia and Donor Age to Chronic Renal Allograft Dysfunction

4. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys

5. High Survival Rates of Kidney Transplants from Spousal and Living Unrelated Donors

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbon Monoxide Protection Seen Through the Lens of Pancreatic Islet Transplantation;Gasotransmitters in Organ Transplantation;2024

2. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024

3. Therapeutic potential of carbon monoxide in hypertension-induced vascular smooth muscle cell damage revisited: From physiology and pharmacology;Biochemical Pharmacology;2022-05

4. Hypoxic preconditioning in renal ischaemia–reperfusion injury: a review in pre-clinical models;Clinical Science;2021-12

5. Carbon Monoxide in Pancreatic Islet Transplantation: A New Therapeutic Alternative to Patients With Severe Type 1 Diabetes Mellitus;Frontiers in Pharmacology;2021-10-11